| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |